Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB25FN3YK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,133
Award facts
- Contract value 100% obligated
- $1,132.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic medication used to treat autoimmune conditions. This firm fixed-price delivery order, valued at $1,132.95, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 21, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. The company's comprehensive DLA contract vehicle enables the supply of a broad range of pharmaceuticals, biologics, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally. This specific delivery order for HUMIRA represents a routine pharmaceutical fulfillment under the broader prime vendor arrangement that allows the Defense Logistics Agency to efficiently procure essential medications for the federal healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FN3YK?
SPE2DB25FN3YK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FN3YK worth?
The government has obligated $1,133 on SPE2DB25FN3YK.
Is contract SPE2DB25FN3YK an order under another contract?
Yes. SPE2DB25FN3YK is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3YK competed?
The extent of competition for SPE2DB25FN3YK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award